Expanding rotavirus vaccine uptake in sub-Saharan Africa

Abstract

It has been proven without equivocation that simple and yet cost-effective medical interventions, such as inoculation against contagious diseases including rotavirus, have the potential to avert substantial morbidity and mortality cases in low-income countries. In the absence of such an intervention, human capital development is adversely affected since children are the most vulnerable to rotavirus. In their paper,1 Charles Okafor and Obinna Ekwunife evaluate the costs and ensuing benefits associated with the introduction of rotavirus vaccine in eight sub-Saharan African countries (Central African Republic, Chad, Comoros, Equatorial Guinea, Gabon, Guinea, Somalia, and South Sudan) contemplating introducing the vaccine.